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Non-	communicable	diseases,	 including	diabetes,	are	partly	 responsible	 for	 the	de-
celeration of improvements of life expectancy in many countries. Diabetes is also 
associated with sleep disturbances. Our aim was to determine whether sleep distur-
bances,	 particularly	 in	 people	with	 diabetes,	were	 associated	with	 increased	mor-
tality	risk.	Data	from	the	UK	Biobank	were	analysed	(n =	487,728,	mean	follow-	up	
time =	8.9	years).	The	primary	exposure	was	sleep	disturbances,	assessed	through	
the question: Do you have trouble falling asleep at night or do you wake up in the 
middle of the night? The primary outcome was mortality. We also dichotomized 
sleep	 disturbances	 into	 “never/sometimes”	 versus	 “usually”	 (frequently),	 and	 com-






associated with greater risk of all- cause mortality than either condition alone. In the 
fully	adjusted	model,	the	hazard	ratio	for	all-	cause	mortality	was	1.11	(95%	CI,	1.07–	
1.15)	 for	 frequent	 sleep	disturbances	 alone,	 1.67	 (95%	CI,	 1.57–	1.76)	 for	 diabetes	
alone	and	1.87	 for	both	 (95%	CI,	1.75–	2.01).	Frequent	 sleep	disturbances	 (experi-
enced	by	more	than	one	quarter	of	the	sample)	were	associated	with	increased	risk	
of all- cause mortality. Mortality risk was highest in those with both diabetes and 
frequent sleep disturbances. Complaints of difficulty falling or staying asleep merit 
attention by physicians.
K E Y W O R D S
cohort	study,	diabetes	mellitus,	insomnia,	non-	communicable	disease,	sleep	disorders
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1  | INTRODUC TION






2018).	The	mortality	 rates	due	to	 these	NCDs	are	expected	to	 in-
crease	by	approximately	54%	between	2016	and	2040,	and	deaths	




led by the United Nations set a goal of reducing the rates of prema-
ture	mortality	due	to	NCD	by	one	third	by	the	year	2030,	but	only	




ant to gain a greater understanding of the underlying causes of NCD- 
associated	mortality.	Here,	we	have	used	data	from	the	UK	Biobank	
to examine the effect of sleep disturbances and their interactions 
with	diabetes,	a	major	NCD,	on	morbidity	and	mortality.






have examined sleep disturbances or insomnia complaints in relation to 
mortality	risk,	and	some	observed	significantly	increased	risk	of	mor-
tality	associated	with	 these	sleep-	related	complaints	 (Li	et	al.,	2014;	
Sivertsen	 et	 al.,	 2014);	 however,	 others	 did	 not	 (Althuis,	 Fredman,	
Langenberg,	&	Magaziner,	1998;	Kripke,	Garfinkel,	Wingard,	Klauber,	








the combination of diabetes and frequent sleep disturbances affects 
mortality risk has not been previously reported.
The aims of the analyses presented here were to determine 
whether sleep disturbances were associated with increased risk of 
all-	cause	and	cardiovascular	disease	(CVD)	mortality	in	a	large	study	
of	adults	in	the	UK	and	to	determine	whether	having	both	frequent	
sleep disturbances and diabetes was more strongly associated with 
mortality than either condition on its own. We hypothesized that 
frequent sleep disturbances would be associated with increased 
mortality	risk,	particularly	in	those	with	diabetes.
2  | METHODS
We	 used	 data	 from	 the	UK	 Biobank,	which	 is	 a	 large,	 prospective,	




dividual within this age range who was registered with the National 







The primary exposure variable was the presence of sleep distur-
bances,	 as	 assessed	 through	 a	 single	 question	 that	 asked:	Do	you	
have trouble falling asleep at night or do you wake up in the mid-
dle	of	the	night?	There	were	three	response	options:	“never/rarely”,	




from	 the	National	 Health	 Service	 for	 England	 and	Wales	 and	 the	
NHS	Central	Register	in	Scotland.	All	details	from	the	death	certifi-
cates	were	provided	to	UK	Biobank	personnel,	who	coded	primary	
cause of death according to ICD10. We classified the ICD10 codes 
I00–	I99	 as	CVD-	related	mortality.	 If	 no	death	was	 recorded	 for	 a	
participant,	they	were	assumed	to	still	be	living.
We examined the interaction between the presence of sleep dis-
turbances	and	the	presence	of	diabetes.	Participants	were	classified	
as having diabetes if they reported a previous diagnosis of diabetes 
or they reported taking insulin. We dichotomized sleep disturbances 
into	“never”/”sometimes”	(infrequently)	versus	“usually”	(frequently)	
and combined this with presence/absence of diabetes to create four 
groups. We also created six groups based on three levels of fre-
quency of sleep disturbance and presence of diabetes.
Covariates	 included	 age,	 sex,	 ethnicity,	 socioeconomic	 depri-
vation,	 smoking,	 sleep	 duration,	 body	 mass	 index	 (BMI)	 and	 co-
morbidities.	Age	was	calculated	based	on	date	of	birth	and	date	of	
examination. Sex was acquired from the central registry and up-
dated	by	the	participant,	if	needed.	Ethnicity	was	self-	identified	and	
the	majority	of	 the	sample	 (94%)	described	themselves	as	 “white”.	
Therefore,	we	dichotomized	ethnicity	into	“white”	and	“non-	white”.	
The measure of socioeconomic deprivation was based on the 
Townsend	deprivation	index	(Townsend	et	al.,	1988),	which	summa-
rizes deprivation in a postcode area based on the rates of unem-
ployment,	absence	of	ownership	of	a	car	and	home,	and	household	
overcrowding. Smoking status was obtained by self- report with the 
following	 categories:	 “never”,	 “previous	 smoker”,	 “current	 smoker”	
and “prefer not to answer”. Sleep duration was based on the ques-
tion:	About	how	many	hours	sleep	do	you	get	in	every	24	h	(please	
include	naps)?	Responses	were	provided	as	integers.	Standing	height	
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was measured using a Seca 240- cm height measure while partici-
pants stood barefoot with posture verified by trained staff. Weight 
was	measured	using	a	Tanita	BC418MA	body	composition	analyser	
and	BMI	(kg/m2)	was	calculated.	Comorbidities	were	recorded	based	
on self- report during an interview by a trained nurse and all comor-





disorders,	 gastrointestinal/abdominal	 disorders,	 depression,	 other	
psychological	disorders	and	cancer.	A	participant	only	needed	a	re-
port	of	one	code	to	be	classified	as	having	 that	comorbidity.	Each	
comorbidity was treated as a separate variable in the analyses.
Insomnia	 symptom	 data	 were	 missing	 for	 1504	 participants,	
9705	participants	were	missing	BMI,	3000	were	missing	sleep	du-
ration,	603	were	missing	the	Townsend	index	and	three	participants	
had	a	negative	 follow-	up	period,	 resulting	 in	a	 final	 sample	size	of	
487,728	participants.	Means	and	standard	deviations	(SD)	or	propor-
tions	(%)	were	calculated	to	describe	the	sample.	Cox	proportional	
hazards models were estimated to determine associations with all- 
cause	and	CVD	mortality.	There	were	two	models,	one	adjusting	for	
age	 and	 sex	only	 and	one	 adjusting	 for	 all	 covariates.	 Further,	we	
examined	sleep	disturbances	alone	(“never/rarely”	was	referent)	as	
well as the four or six groups based on frequency of sleep distur-
bances	and	diabetes	(absence	of	both	was	referent).	In	addition,	to	
determine	whether	 the	 two	groups	with	diabetes	differed,	we	 re-
peated the analysis with the four groups using the diabetes- alone 
group	as	the	referent.	Finally,	we	tested	an	interaction	term	between	
diabetes and sleep disturbances to determine whether the associa-




Table 1 describes the sample in full as well as stratified by sleep 
disturbances.	 Approximately	 one	 quarter	 of	 the	 sample	 reported	







but not frequent sleep disturbances and 2% had both. During the 
mean	follow-	up	period	of	8.9	years,	there	were	19,177	deaths	from	
all	causes	and	3,874	deaths	from	CVD.
Frequent sleep disturbances were significantly associated with 
all-	cause	mortality	(Figure	1).	In	age-	and	sex-	adjusted	models,	fre-
quent sleep disturbances were associated with increased risk of 
all-	cause	mortality	 (hazard	 ratio	 [HR],	 1.31;	95%	confidence	 inter-
val	[CI],	1.26–	1.37),	which	remained	significant	in	the	fully	adjusted	
model	 (HR.	 1.13;	 95%	CI,	 1.09–	1.18).	 Frequent	 sleep	disturbances	
were	significantly	associated	with	 increased	 risk	of	CVD	mortality	
in	the	age-	and	sex-	adjusted	models	(HR,	1.33;	95%	CI,	1.22–	1.44)	
but this association did not remain significant in the fully adjusted 
models	(HR.	1.02;	95%	CI,	0.93–	1.12).
The analysis of sleep disturbances and diabetes demonstrated 
that the presence of either frequent sleep disturbances or di-




N 487,728 118,217	(24.2%) 233,177	(47.8%) 136,334	(28.0%)
Age	(years)a  56.5	(8.1) 55.2	(8.4) 56.6	(8.1) 57.5	(7.7)
Femalea  54.4% 42.5% 56.3% 61.7%
White ethnicitya  94.4% 93.6% 94.2% 95.5%
Smoking statusa 
Never 54.6% 57.1% 55.4% 51.1%
Previous 34.6% 32.3% 34.1% 37.3%
Current 10.5% 10.3% 10.1% 11.3%
Depressiona  5.6% 3.3% 5.2% 8.2%
Diabetesa  5.0% 4.4% 4.6% 6.3%
BMI	(kg/m2)a  27.4	(4.8) 27.2	(4.5) 27.3	(4.7) 27.9	(5.1)





TA B L E  1   Description of full sample 
and by insomnia symptom frequency
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compared	 to	 those	who	 had	 neither	 condition	 (Figure	 1).	 In	 the	
fully	adjusted	model,	the	hazard	ratio	for	all-	cause	mortality	was	
1.11	 (95%	 CI,	 1.07–	1.15)	 for	 frequent	 sleep	 disturbances	 alone,	
1.67	(95%	CI,	1.57–	1.76)	for	diabetes	alone	and	1.87	for	both	(95%	
CI,	1.75–	2.01).	In	addition,	the	group	who	had	both	frequent	sleep	
disturbances and diabetes demonstrated a greater risk of all- cause 
mortality	 compared	 to	 those	with	 only	 diabetes	 (HR,	 1.12;	 95%	
CI,	 1.04–	1.22).	 Both	 groups	with	 diabetes	 had	 an	 increased	 risk	
of	CVD	mortality	compared	to	those	with	neither	frequent	sleep	
disturbances	nor	 diabetes.	 In	 fully	 adjusted	models,	 the	HR	was	
2.04	 (95%	 CI,	 1.84–	2.27)	 for	 diabetes	 alone	 and	 2.11	 (95%	 CI,	
1.85–	2.40)	for	both.	There	was	no	significant	difference	in	risk	of	
CVD	mortality	between	 the	 two	diabetes	groups	 (HR	1.03,	95%	
CI	0.89–	1.20	for	both	frequent	 insomnia	and	diabetes	compared	
to	 diabetes	 alone).	 The	 interaction	 between	 sleep	 disturbances	
and diabetes was not significant in either the model predicting 
all-	cause	mortality	 (p =	0.40)	or	 the	model	predicting	CVD	mor-
tality	 (p =	 0.68),	 which	 indicates	 the	 association	 between	 sleep	
disturbances and mortality did not differ between those with and 
without diabetes. In analyses that created six groups based on 
diabetes	 and	 three	 levels	 of	 sleep	 disturbances	 (Table	 S2),	 simi-
lar	associations	were	observed.	 In	the	fully	adjusted	models,	 the	
group without diabetes but with frequent sleep disturbances and 
all three groups with diabetes had an increased risk of all- cause 
mortality compared to the group with neither diabetes nor sleep 
disturbances.
4  | DISCUSSION
In	 this	 large,	 UK-	based	 population	 study,	 we	 observed	 significant	
associations between frequent sleep disturbances and risk of all- 
cause mortality. Frequent sleep disturbances were experienced by 
more	 than	 one	 quarter	 of	 the	 sample,	 and	 thus	 are	 highly	 preva-
lent	 in	 the	UK,	which	 is	 consistent	with	other	observational	 stud-
ies	 (Ohayon,	2002).	 In	addition,	 individuals	with	diabetes	who	also	
experienced frequent sleep disturbances had a greater risk of mor-
tality than those with diabetes who did not report frequent sleep 
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disturbances.	Further,	 the	association	between	frequent	sleep	dis-
turbances and mortality risk did not differ between those who did 
and did not have diabetes.
Our	findings	 from	this	UK	cohort	are	consistent	with	studies	
from	other	countries.	A	study	from	Norway	assessed	self-	reported	
insomnia	 in	 adults	 aged	 40–	45	 years	 at	 baseline	 and	 followed	
them	 for	 13–	15	 years.	 They	 reported	 that	 insomnia	 at	 baseline	
was	a	 significant	predictor	of	all-	cause	mortality	 (HR,	3.34;	95%	
CI,	 1.67–	6.69)	 (Sivertsen	 et	 al.,	 2014).	 A	 large	 study	 of	 middle-	




that adults who reported sleep disturbances nearly every day had 
an	increased	risk	of	mortality	over	approximately	16	years	(Chien	




assessment	was	 not	 (Parthasarathy,	Vasquez,	&	Halonen,	 2015).	
Not all studies that examined indicators of insomnia observed 
significant	 associations	 with	 mortality	 risk	 (Althuis	 et	 al.,	 1998;	
Kripke	et	al.,	2002;	Lovato	&	Lack,	2019;	Rockwood	et	al.,	2001).	





Norway followed participants for approximately 11 years and found 
that risk of acute myocardial infarction was significantly higher 
for individuals who had difficulty falling asleep almost every night 
(HR,	1.45;	95%	CI,	1.18–	1.80)	and	for	 individuals	who	had	difficul-
ties	maintaining	sleep	almost	every	night	 (HR,	1.30;	95%	CI,	1.01–	
1.68)	 compared	 to	 those	 who	 never	 have	 these	 sleep	 difficulties	
(Laugsand,	 Vatten,	 Platou,	 &	 Janszky,	 2011).	 The	 same	 study	 also	

















studies have found a strong association between obstructive sleep 
apnea	(OSA)	and	type	2	diabetes	(Huang	et	al.,	2018;	Subramanian	
et	 al.,	 2019),	 and	OSA	 impairs	 sleep	 quality.	 Further,	 some	 obser-
vational studies have found that among people with type 2 diabe-
tes,	worse	sleep	quality	is	associated	with	higher	haemoglobin	A1c,	
suggesting	 poorer	 glycaemic	 control	 (Knutson	 et	 al.,	 2006,	 2011).	
A	meta-	analysis	 of	 nine	 studies	 among	 adults	 with	 type	 2	 diabe-
tes also found that poor sleep quality was associated with higher 
haemoglobin	A1c	 (Lee,	Ng,	&	Chin,	 2017),	 and	 insomnia	 has	 been	
identified as a risk factor for type 2 diabetes both in observational 
(Vgontzas	et	al.,	2009)	and	Mendelian	randomization	studies	(Yuan	
&	Larsson,	2020).	Experimental	studies	that	 impaired	sleep	quality	




be a mechanism leading to the increased risk of mortality in people 
with diabetes and frequent sleep disturbances.





somewhat. We also do not have access to measures of hypnotic or al-
cohol use in our dataset and these could be important confounders or 
mediators of the association between sleep disturbances and mortal-
ity.	Another	limitation	is	that	the	mean	follow-	up	time	is	only		8.9	years	
and	a	 longer	period	would	 result	 in	a	higher	number	of	mortalities,	
which	could	increase	power	for	the	CVD	mortality	analyses.	Finally,	
sleep	disturbances	are	based	on	a	single	self-	reported	question,	which	
did	 not	 assess	 daytime	 consequences,	 and	 are	 not	 equivalent	 to	 a	
clinically	diagnosed	insomnia	disorder.	However,	this	same	question	





ple who report sleep disturbances are likely to be a heterogeneous 
group	with	respect	to	the	underlying	pathology.	Further,	these	data	
do	not	include	objective	measures	of	sleep	quality,	sleep	duration	or	
sleep- disordered breathing so we cannot identify subtypes of insom-
nia or other sleep disorders. The data presented here suggest that 
regardless	of	the	cause	of	the	sleep	disturbance,	reporting	sleep	dis-
turbances on a frequent basis is an important signal of an elevated risk 








plications. The results are also relevant to clinical practice and fre-
quent sleep disturbances may be an important health indicator for 
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clinicians	 to	 consider,	 particularly	 for	diabetes	patients.	We	 found	
that a single question was sufficient to detect mortality risk and cli-
nicians could use a similar brief question to identify patients who 
may need additional therapy or support.
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